SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-290681
Filing Date
2015-08-14
Accepted
2015-08-14 07:38:17
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d34509d10q.htm 10-Q 460788
2 EX-31.1 d34509dex311.htm EX-31.1 8925
3 EX-31.2 d34509dex312.htm EX-31.2 8922
4 EX-32.1 d34509dex321.htm EX-32.1 5412
  Complete submission text file 0001193125-15-290681.txt   2008805

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20150630.xml EX-101.INS 245282
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20150630.xsd EX-101.SCH 23704
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20150630_cal.xml EX-101.CAL 32268
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20150630_def.xml EX-101.DEF 73533
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20150630_lab.xml EX-101.LAB 210713
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20150630_pre.xml EX-101.PRE 142331
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 151052544
SIC: 2834 Pharmaceutical Preparations